Metabolic remission precedes possible weight regain after gastric bypass surgery

Author:

Rogova Oksana1,Herzog Katharina1,Al‐Majdoub Mahmoud2,Miskelly Michael3,Lindqvist Andreas3,Bennet Louise45ORCID,Hedenbro Jan L.36,Wierup Nils3,Spégel Peter1ORCID

Affiliation:

1. Department of Chemistry, Centre for Analysis and Synthesis Lund University Lund Sweden

2. Unit of Molecular Metabolism, Department of Clinical Sciences Malmö Lund University Malmö Sweden

3. Neuroendocrine Cell Biology, Department of Experimental Medical Science Lund University Diabetes Centre Malmö Sweden

4. Department of Clinical Sciences Malmö Lund University Malmö Sweden

5. Clinical Research and Trial Centre Lund University Hospital Lund Sweden

6. Department of Surgery, Department of Clinical Sciences Lund Lund University Lund Sweden

Abstract

AbstractObjectiveSome patients regain weight to a variable extent from 1 year after Roux‐en‐Y gastric bypass surgery (RYGB), though rarely reaching preoperative values. The aim of the present study was to investigate whether, when, and to what extent metabolic remission occurs.MethodsFasting metabolite and lipid profiles were determined in blood plasma collected from a nonrandomized intervention study involving 148 patients before RYGB and at 2, 12, and 60 months post RYGB. Both short‐term and long‐term alterations in metabolism were assessed. Anthropometric and clinical variables were assessed at all study visits.ResultsThis study found that the vast majority of changes in metabolite levels occurred during the first 2 months post RYGB. Notably, thereafter the metabolome started to return toward the presurgical state. Consequently, a close‐to‐presurgical metabolome was observed at the time when patients reached their lowest weight and glucose level. Lipids with longer acyl chains and a higher degree of unsaturation were altered more dramatically compared with shorter and more saturated lipids, suggesting a systematic and reversible lipid remodeling.ConclusionsRemission of the metabolic state was observed prior to notable weight regain. Further and more long‐term studies are required to assess whether the extent of metabolic remission predicts future weight regain and glycemic deterioration.

Funder

ALF

Horizon 2020 Framework Programme

Swedish Diabetes Foundation

Novo Nordisk Fonden

Swedish Foundation for Strategic Research

Vetenskapsrådet

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3